Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Fumaric Acid

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Fumaric Acid?

Fumaric Acid is an investigational drug.

There have been 15 clinical trials for Fumaric Acid. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.

The most common disease conditions in clinical trials are Psoriasis, Sclerosis, and Lupus Erythematosus, Systemic. The leading clinical trial sponsors are Medical University of Vienna, Jochen Schmitt., and Singapore General Hospital.

There are six hundred and forty-two US patents protecting this investigational drug and seven international patents.

Recent Clinical Trials for Fumaric Acid
A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque PsoriasisLEO PharmaPhase 4
A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque PsoriasisJanssen-Cilag G.m.b.HPhase 3
APremilast After FumaRic Acid Ester TreatmentProf. Kristian ReichN/A

See all Fumaric Acid clinical trials

Clinical Trial Summary for Fumaric Acid

Top disease conditions for Fumaric Acid
Top clinical trial sponsors for Fumaric Acid

See all Fumaric Acid clinical trials

US Patents for Fumaric Acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fumaric Acid   Start Trial Carbostyril derivatives Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)   Start Trial
Fumaric Acid   Start Trial Indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same Fujisawa Pharmaceutical Company, Ltd. (Osaka, JP)   Start Trial
Fumaric Acid   Start Trial Method for forming a metal film on the surface of a substrate metal Harima Chemicals, Inc. (Hyogo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.